Pathophysiology of erectile dysfunction

Journal of Sexual Medicine

Volumn 2, Issue 1, 2005, Pages 26-39

  Sáenz de Tejada, Iñigo ^a   Angulo, Javier ^a   Cellek, Selim ^b   González Cadavid, Nestor ^c   Heaton, Jeremy ^d   Pickard, Robert ^e   Simonsen, Ulf ^f  

^a Fund Invest Desarrollo/Andrologia   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d QUEEN S UNIVERSITY   (Canada)

^e FREEMAN HOSPITAL   (United Kingdom)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

Antiandrogens; Diabetes; Diuretics; Endothelium dependent dilation; Endothelium derived hyperpolarizing factor; Erectile dysfunction; Hypercholesterolemia; Hypertension; Nitric oxide; Reactive oxygen species; Serotonin reuptake inhibitors

Indexed keywords

ACEBUTOLOL; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; APOMORPHINE; BENDROFLUMETHIAZIDE; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CLONIDINE; CLOZAPINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; FLUPENTIXOL; FREE RADICAL; HALOPERIDOL; METHYLDOPA; NEUROLEPTIC AGENT; NITRIC OXIDE SYNTHASE; PLACEBO; PRACTOLOL; PROPRANOLOL; PSYCHOTROPIC AGENT; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG;

ARTERY; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; CONSULTATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG CLASSIFICATION; DRUG MECHANISM; ENDOTHELIUM; EPIDEMIOLOGICAL DATA; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERNATIONAL COOPERATION; INTERPERSONAL COMMUNICATION; MEDICAL EXPERT; MEDICAL LITERATURE; MEDICAL SOCIETY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PELVIS SURGERY; PENIS ERECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SEXUALITY; SPINAL CORD INJURY; SYSTEMATIC REVIEW; UROLOGY; VASOCONSTRICTION; VASODILATATION;

EID: 16444387316     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2005.20103.x     Document Type: Article

References (150)

1. Abicht JH. Testing the autonomic system. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Berlin: Springer Verlag; 1991:187-94.
2. Aboseif S, Shinohara K, Borirakchanyavat S, Deirmenjian J, Carroll PR. The effect of cryosurgical ablation of the prostate on erectile function. Br J Urol 1997;80:918-22.
3. Chuang AT, Steers WD. Neurophysiology of penile erection. In: Carson CC, Kirby R, Goldstein I, editors. Textbook of erectile dysfunction. Oxford: ISIS Medical Media; 1999:59-72.
4. Caetano DB, Farias DS, De Azevedo Filho HC, Spinelli C. Disturbances of sexual potency in patients with basilar impression and Arnold-Chiari malformation. J Neurol Neurosurg Psychiatry 1975;38:598-600.
5. Cahn D, Melman A, Valcic M, Christ GJ. Forskolin - A promising new adjunct to intracavernous pharmacotherapy. J Urol 1996;155:1789-94.
6. Carrier S, Zvara P, Nunes L, Kour NW, Rehman J, Lue TF. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol 1995;153:1722-7.
7. Christ GJ, Melman A. The application of gene therapy to the treatment of erectile dysfunction. Int J Impot Res 1998;10:111-12.
8. Adsan O, Ozturk B, Cetinkaya M, Kulacoglu S, Memis A, Guner E. The value of cavernous body biopsy in evaluating of impotent men. Arch Ital Urol Androl 1997;69:151-3.
9. Ali ST, Shaikh RN, Siddiqi A. HIV-1 associated neuropathies in males; impotence and penile electrodiagnosis. Acta Neurol Belg 1994;94:194-9.
10. Amelar RD, Dubin L. Impotence in the low-back syndrome. JAMA 1971;216:520.
11. Autieri MV, Melman A, Christ GJ. Identification of a down-regulated mRNA transcript in corpus cavernosum from diabetic patients with erectile dysfunction. Int J Impot Res 1996;8:69-73.
12. Beck RO, Betts CD, Fowler CJ. Genitourinary dysfunction in multiple system atrophy: Clinical features and treatment in 62 cases. J Urol 1994;151:1336-41.
13. Betts CD, Jones SJ, Fowler CG, Fowler CJ. Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition. Brain 1994;117(Part 6): 1303-10.
14. Bors E, Comarr AE. Neurological urology. Baltimore: University Park Press; 1971.
15. Brien SE, Heaton JPW, Adams MA. Interactions between apomorphine and sildenafil: Evidence for normalization of erections during hyperadrenergic stimulation. J Urol 1999;161(Abstract):219.
16. Costabile RA, Spevak M, Fishman IJ, Govier FE, Hellstrom WJ, Shabsign R, Nemo KJ, Rapport JL, Tam PY, Weldom KL, Gerundheit N. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol 1998;160:1325-8.
17. Courtois FJ, MacDougall JC, Sachs BD. Erectile mechanism in paraplegia. Physiol Behav 1993;53: 721-6.
18. Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles. J Urol 1991;145:998.
19. Leach GE. Potency evaluated after radical retropubic prostatectomy. Clin Perp 1992;5:1.
20. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la Disfuncion Erectil Masculina study. J Urol 2001;166:569-74.
21. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
22. Sullivan ME, Thompson CS, Dashwood MR, Khan MA, Jeremy JY, Morgan RJ, Mikhailidis DP. Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999;43:658-65.
23. Morley JE, Korenman SG, Kaiser FE, Mooradian AD, Viosca SP. Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men. Am J Med 1988;84:445-8.
24. Azadzoi KM, Goldstein I. Erectile dysfunction due to atherosclerotic vascular disease: The development of an animal model. J Urol 1992;147:1675-81.
25. Azadzoi KM, Park K, Andry C, Goldstein I, Siroky MB. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model. J Urol 1997;157:1011-7.
26. Nehra A, Azadzoi KM, Moreland RB, Pabby A, Siroky MB, Krane RJ, Goldstein I, Udelson D. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol 1998;159:2229-36.
27. Azadzoi KM, Krane RJ, Saenz de Tejada I, Goldstein I, Siroky MB. Relative roles of cyclooxygenase and nitric oxide synthase pathways in ischemia-induced increased contraction of cavernosal smooth muscle. J Urol 1999;161:1324-8.
28. Azadzoi KM, Goldstein I, Siroky MB, Traish AM, Krane RJ, Saenz de Tejada I. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 1998;160:2216-22.
29. Ahn TY, Gomez-Coronado D, Martinez V, Cuevas P, Goldstein I, Saenz de Tejada I. Enhanced contractility of rabbit corpus cavernosum smooth muscle by oxidized low density lipoproteins. Int J Impot Res 1999;11:9-14.
30. Morita R, Morimoto S, Koh E, Fukuo K, Kim S, Itoh K, Taniguchi K, Onishi T, Ogihara T. Low-density lipoprotein and apoprotein-B induce increases in inositol trisphosphate and cytosolic free Ca2+ via pertussis toxin-sensitive Gtp-binding protein in vascular smooth-muscle cells. Biochem Int 1989;18:647-53.
31. Azadzoi KM, Saenz de Tejada I. Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1991;146:238-40.
32. Kim JH, Klyachkin ML, Svendsen E, Davies MG, Hagen PO, Carson CC. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth-muscle cell dysfunction. J Urol 1994;151:198-205.
33. Kim SC, Kim IK, Seo KK, Baek KJ, Lee MY. Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits. Urol Res 1997;25:341-6.
34. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, De Shabsigh A, La TA, Hayek OR, Shabsigh R. Hypertension is associated with severe erectile dysfunction. J Urol 2000;164:1188-91.
35. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40-69 years old: Longitudinal results from the Massachusetts male aging study. J Urol 2000;163:460-3.
36. Kaufman JM, Hatzichristou DG, Mulhall JP, Fitch WP, Goldstein I. Impotence and chronic renal failure: A study of the hemodynamic pathophysiology. J Urol 1994;151:612-8.
37. Chitaley K, Wingard CJ, Clinton Webb R, Branam H, Stopper VS, Lewis RW, Mills TM. Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 2001;7:119-22.
38. Dorrance AM, Lewis RW, Mills TM. Captopril treatment reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats. Int J Impot Res 2002;14:494-7.
39. Behr-Roussel D, Chamiot-Clerc P, Bernabe J, Mevel K, Alexandre L, Safar ME, Giuliano F. Erectile dysfunction in spontaneously hypertensive rats: Pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003;284:R682-8.
40. Hale TM, Okabe H, Bushfield TL, Heaton JP, Adams MA. Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol 2002;168:348-54.
41. Tarhan F, Kuyumcuoglu U, Kolsuz A, Ozgul A, Canguven O. Cavernous oxygen tension in the patients with erectile dysfunction. Int J Impot Res 1997;9:149-53.
42. Daley JT, Brown ML, Watkins MT, Traish AM, Huang YUE-HUA, Moreland RB, Saenz de Tejada I. Prostanoid production in rabbit corpus cavernosum: I. Regulation by oxygen tension. J Urol 1996;155:1482.
43. 1 suppresses the induction of collagen synthesis by transforming growth factor-β1 in human corpus cavernosum smooth muscle. J Urol 1995;153:826-34.
44. Nehra A, Gettman MT, Nugent M, Bostwick DG, Barrett DM, Goldstein I, Krane RJ, Moreland RB. Transforming growth factor-beta 1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo. J Urol 1999;162:910-15.
45. Saenz de Tejada I, Moroukian P, Tessier J, Kim JJ, Goldstein I, Frohrib D. The trabecular smooth muscle modulates the capacitor function of the penis. Studies on a rabbit model. Am J Physiol 1991;260:H1590-5.
46. Mulvany MJ. Small artery remodeling in hypertension. Curr Hypertens Rep 2002;4:49-55.
47. Okabe H, Hale TM, Kumon H, Heaton JP, Adams MA. The penis is not protected - in hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int J Impot Res 1999;11:133-40.
48. Toblli JE, Stella I, Inserra F, Ferder L, Zeller F, Mazza ON. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 2000;13:686-92.
49. Hale TM, Okabe H, Heaton JP, Adams MA. Antihypertensive drugs induce structural remodeling of the penile vasculature. J Urol 2001;166:739-45.
50. Schubert R, Mulvany MJ. The myogenic response: Established facts and attractive hypotheses. Clin Sci (Colch) 1999;96:313-26.
51. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999;79:387-423.
52. Simonsen U, Garcia-Sacristan A, Prieto D. Penile arteries and erection. J Vasc Res 2002;39:283-303.
53. Norman RA Jr, Dzielak DJ. Immunological dysfunction and enhanced sympathetic activity contribute to the pathogenesis of spontaneous hypertension. J Hypertens Suppl 1986;4:S437-9.
54. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999;34:724-8.
55. Tong YC, Hung YC, Lin SN, Cheng JT. The norepinephrine tissue concentration and neuropeptide Y immunoreactivity in genitourinary organs of the spontaneously hypertensive rat. J Auton Nerv Syst 1996;56:215-18.
56. Simonsen U, Contreras J, Garcia-Sacristan A, Martinez AC. Effect of sildenafil on non adrenergic non-cholinergic neurotransmission in bovine penile small arteries. Eur J Pharmacol 2001;412:155-69.
57. Simonsen U, Prieto D, Saenz de Tejada I, Garcia-Sacristan A. Involvement of nitric oxide in the non-adrenergic non-cholinergic neurotransmission of horse deep penile arteries: Role of charybdotoxin-sensitive K(+)-channels. Br J Pharmacol 1995;116: 2582-90.
58. Simonsen U, Prieto D, Delgado JA, Hernandez M, Resel L, Saenz de Tejada I, Garcia-Sacristan A. Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries. Clin Sci (Colch) 1997;92:269-75.
59. Martinez C, Simonsen U. Decreased erectile function in renal hypertensive rats. Abstracts of the 5th Congress of the European Association for Clinical Pharmacology and Therapeutics. Pharmacol Toxicol 2001;89(Suppl 1):1-163.
60. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
61. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222-9.
62. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000;87:840-4.
63. Konishi M, Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983;5:881-6.
64. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986;8:344-8.
65. Cosentino F, Patton S, D'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, Luscher TF. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998;101:1530-7.
66. Yang D, Feletou M, Boulanger CM, Wu HF, Levens N, Zhang JN, Vanhoutte PM. Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol 2002;136:104-10.
67. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: Evidence for an involvement of protein kinase C. Kidney Int 1999;55: 252-60.
68. Vega GW, Roson MI, Bellver A, Celentano MM, de la Riva IJ. Nitric oxide and superoxide anions in vascular reactivity of renovascular hypertensive rats. Clin Exp Hypertens 1995;17:817-35.
69. Paniagua OA, Bryant MB, Panza JA. Transient hypertension directly impairs endothelium-dependent vasodilation of the human microvasculature. Hypertension 2000;36:941-4.
70. Koldny RC, Kahn CB, Goldstein HH, Barnett DM. Sexual function in diabetic men. Diabetes 1973;23:306-9.
71. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980;18:279-83.
72. McCulloch DK, Young RJ, Prescott RJ, Campbell IW, Clarke BF. The natural history of impotence in diabetic men. Diabetologia 1984;26:437-40.
73. Dunsmuir WD, Holmes SAV. The aetiology and management of erectile, ejaculatory and fertility problems in men with diabetes mellitus. Diabet Med 1996;13:700-8.
74. Pieper GM, Dondlinger LA. Plasma and vascular tissue arginine are decreased in diabetes: Acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. J Pharmacol Exp Ther 1997;283:684-91.
75. Bivalacqua TJ, Hellstrom WJG, Kadowitz PJ, Champion HC. Increased expression of arginase II in human diabetic corpus cavernosum: In diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 2001;283:923-7.
76. Ganz MB, Seftel A. Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am J Physiol Endocrinol Metab 2000; 278:E146-52.
77. Angulo J, Cuevas P, Fernández A, Gabancho S, Videla S. Calcium dobesilate potentiates endothelium-derived hyperpolarizing factor-mediated relaxation of human penile resistance arteries. Br J Pharmacol 2003;139:854-62.
78. Angulo J, Cuevas P, Fernandez A, Gabancho S, Allona A, Martin-Morales A, Moncada I, Videla S, Saenz de Tejada I. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 2003;312:1202-8.
79. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 1990;173: 932-9.
80. Angulo J, Sanchez-Ferrer CF, Peiro C, Marin J, Rodriguez Mañas L. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin. Possible mechanisms involved. Hypertension 1996;28: 583-92.
81. Cartledge JJ, Eardley I, Morrison JFB. Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human hemoglobin. BJU Int 2000;85: 735-41.
82. Seftel AD, Vazin ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, Polak J, Wang RZ, Ferguson K, Block C, Haas C. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition and possible effect through iNOS or eNOS. Urology 1997;50:1016-26.
83. Cartledge JJ, Eardley I, Morrison JFB. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smmoth muscle relaxation seen in diabetes. BJU Int 2001;87:402-7.
84. Usta MF, Bivalacqua TJ, Yang DY, Ramanitharan A, Sell DR, Viswanathan A, Monnier VM, Hellstrom WJ. The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats. J Urol 2003;170:1437-42.
85. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus. Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105:1656-62.
86. Gocmen C, Secilmis A, Kumcu EK, Ertug PU, Onder S, Dikmen A, Baysal F. Effects of vitamin E and sodium selenate on neurogenic and endothelial relaxation of corpus cavernosum in the diabetic mouse. Eur J Pharmacol 2000;398:93-8.
87. Khan MA, Thompson CS, Jeremy JY, Mumtaz FH, Mikhailidis P, Morgan RJ. The effect of superoxide dismutase on nitric oxide mediated and electrical field stimulated diabetic rabbit cavernosal smooth muscle relaxation. BJU Int 2001;87:98-103.
88. Keegan A, Cotter MA, Cameron NE. Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia 1999;42:343-50.
89. Stief CG, Bahren W, Scherb W, Gall H. Primary erectile dysfunction. J Urol 1989;141:315-9.
90. Woodhouse CR. Sexual function in boys born with exstrophy, myelomeningocele, and micropenis. Urology 1998;52:3-11.
91. Teloken C, Busato WF Jr, Neto JF, Hartmann A, Winckler J, Souto CA. Congenital abnormality of corpora cavernosa and erectile dysfunction: A case report. J Urol 1993;149:1135-6.
92. Aboseif SR, Baskin LS, Yen TS, Lue TF. Congenital defect in sinusoidal smooth muscles: A cause of organic impotence. J Urol 1992;148:58-60.
93. Montague DK, Lakin MM, Angermeier KW, Lammert GK. Primary erectile dysfunction in a man with congenital isolation of the corpora cavernosa. Urology 1995;46:114-6.
94. Lue TF. Surgery for crural venous leakage. Urology 1999;54:739-41.
95. Kim DS, Choi SI, Lee HS, Park JK, Yi HK. Determination of human angiotensin converting enzyme (ACE) gene polymorphism in erectile dysfunction: Frequency differences of ACE gene polymorphism according to the method of analysis. Clin Chem Lab Med 2001;39:11-4.
96. Carson CC, Patel MP. The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients. Adv Ren Replace Ther 1999;6:296-309.
97. Rosas SE, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, Grossman E, Glasser D, Feldman HI. Prevalence and determinants of erectile dysfunction in haemodialysis patients. Kidney Int 2001;59:2259-66.
98. Ayub W, Fletcher S. End-stage renal disease and erectile dysfunction. Is there any hope? Nephrol Dial Transplant 2000;15:1525-8.
99. Mendes Ribeiro AC, Brunini TM, Ellory JC, Mann GE. Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure. Cardiovasc Res 2001;49:697-712.
100. Bagcivan I, Kilicarslan H, Sarac B, Gokce G, Yildirim S, Ayan S, Sarioglu Y. The evaluation of the effects of renal failure on erectile dysfunction in a rabbit model of chronic renal failure. BJU Int 2003;91:697-701.
101. Kilicarslan H, Yildirim S, Bagcivan I, Ayan S, Sarac B, Sarioglu Y. Effect of chronic renal failure on the purinergic responses of corpus cavernosal smooth muscle in rabbits. BJU Int 2002;90:596-600.
102. Ribeiro RC, Neves FA, Albuquerque RH, Dorea JG, Martinelli JG, da Costa e Silva A. Absence of zinc testicular deficiency in the sexual dysfunction of experimentally induced uremic rats. Nephron 1982;30(4):361-3.
103. Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002;39:135-41.
104. Vaziri ND. Effect of chronic renal failure on nitric oxide metabolism. Am J Kidney Dis 2001;38(4 suppl 1):S74-9.
105. Vita G, Bellinghieri G, Trusso A, Costantino G, Santoro D, Monteleone F, Messina C, Savica V. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 1999;56:232-7.
106. Campese VM, Procci WR, Levitan D, Romoff MS, Goldstein DA, Massry SG. Autonomic nervous system dysfunction and impotence in uremia. Am J Nephrol 1982;2:140-3.
107. Nogues MA, Starkstein S, Davalos M, Berthier M, Leiguarda R, Garcia H. Cardiovascular reflexes and pudendal evoked responses in chronic haemodialysis patients. Funct Neurol 1991;6:359-65.
108. Rodger RS, Sheldon WL, Watson MJ, Dewar JH, Wilkinson R, Ward MK, Kerr DN. Zinc deficiency and hyperprolactinaemia are not reversible causes of sexual dysfunction in uraemia. Nephrol Dial Transplant 1989;4:888-92.
109. Schaefer RM, Kokot F, Wernze H, Geiger H, Heidland A. Improved sexual function in hemodialysis patients on recombinant erythropoietin: A possible role for prolactin. Clin Nephrol 1989;31: 1-5.
110. Mahajan SK, Abbasi AA, Prasad AS, Rabbani P, Briggs WA, McDonald FD. Effect of oral zinc therapy on gonadal function in hemodialysis patients. A double-blind study. Ann Intern Med 1989;97:357-61.
111. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-5.
112. Chang SW, Fine R, Siegel D, Chesney M, Blavk D, Hulley SB. The impact of diuretic therapy on reported sexual function. Arch Intern Med 1991; 151:2402-8.
113. Croog SH, Levine S, Sudilovsky A, Baume RM, Clive J. Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications. Arch Intern Med 1988;148:788-94.
114. Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propanolol for the treatment of mild hypertension. Lancet 1981;2:539-43.
115. Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ. Long term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of mild hypertension study (TOMHS). Hypertension 1997; 29:8-14.
116. Andersson K-E, Wagner G. Physiology of erection. Physiol Rev 1995;75:191-236.
117. Srilatha B, Adaikan PG, Arulkumaran S, Ng SC. Sexual dysfunction related to antihypertensive agents: Results from the animal model. Int J Impot Res 1999;11:107-13.
118. Suzuki H, Tominaga T, Kumagai H, Saruta T. Effects of first-line antihypertensive agents on sexual function and sex hormones. J Hypertens Suppl 1988;6:S649-51.
119. Flack JM. The effect of doxazosin on sexual function in patients with benign prostatic hyperplasia, hypertension, or both. Int J Clin Pract 2002;56: 527-30.
120. Hogan MJ, Wallin JD, Baer RM. Antihypertensive therapy and male sexual dysfunction. Psychosomatics 1980;21:234-7.
121. Llisterri JL, Lozano Vidal JV, Aznar Vicente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA, Ferrario CM. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001;321:336-41.
122. Cushman WC, Cohen JD, Jones RP, Marbury TC, Rhoades RB, Smith LK. Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension. Am J Hypertens 1998;11:23-30.
123. Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 1995;56:137-41.
124. Sullivan G, Lukoff D. Sexual side effects of antipsychotic medication: Evaluation and interventions. Hosp Community Psychiatry 1990;41: 1238-41.
125. Naganuma H, Egashira T, Fujii I. Neuroleptics induce penile erection in the rabbit. Clin Exp Pharmacol Physiol 1993;20:177-83.
126. Wirshing DA, Pierre JM, Marder SR, Saunders CS, Wirshing WC. Sexual side effects of novel antipsychotic medications. Schizophr Res 2002;56: 25-30.
127. Kotin J, Wilbert DE, Verburg D, Soldinger SM. Thioridazine and sexual dysfunction. Am J Psychiatry 1976;133:82-5.
128. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 1999;19:67-85.
129. Keltner NL, McAfee KM, Taylor CL. Mechanisms and treatments of SSRI-induced sexual dysfunction. Perpect Psychiatr Care 2002;38:111-6.
130. Tang Y, Rampin O, Calas A, Facchinetti P, Giuliano F. Oxytocinergic and serotonergic innervation of identified lumbosacral nuclei controlling penile erection in the male rat. Neuroscience 1998; 82:241-54.
131. Maeda N, Matsuoka N, Yamaguchi I. Role of the dopaminergic, serotonergic and cholinergic link in the expression of penile erection in rats. Jap J Pharmacol 1994;66:59-66.
132. Michelson D, Schmidt M, Lee J, Tepner R. Changes in sexual function during acute and six-month fluoxetine therapy: A prospective assessment. J Sex Marital Ther 2001;27:289-302.
133. Croft H, Settle E Jr, Houser T, Batey SR, Donahue RM, Ascher JA. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999;21:643-58.
134. Labbate LA, Grimes JB, Arana GW. Serotonin re-uptake antidepressant effects on sexual function in patients with anxiety disorders. Biol Psychiatry 1998;43:904-7.
135. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: A randomized controlled trial. JAMA 2003;289:56-64.
136. Aizenberg D, Gur S, Zemishlany Z, Granek M, Jeczmien P, Weizman A. Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin re-uptake inhibitors. Clin Neuropharmacol 1997;20:210-4.
137. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 2000;61:276-81.
138. Mendels J, Kiev A, Fabre LF. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia. Depress Anxiety 1999;9:54-60.
139. Angulo J, Peiro C, Sanchez-Ferrer CF, Gabancho S, Cuevas P, Gupta S, Saenz de Tejada I. Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue. Br J Pharmacol 2001;134: 1190-4.
140. Angulo J, Bischoff E, Gabancho S, Cuevas P, Saenz de Tejada I. Vardenafil reverses erectile dysfunction induced by paroxetine in the rat. Int J Impot Res 2003;15:90-3.
141. Angulo J, Cuevas P, Gabancho S, La Fuente JM, Rolo F, Cruz N, Gupta S, Saenz de Tejada I. Efectos de los antidepresivos paroxetina, venlafaxina y escitalopram sobre las respuestas erétiles en la rata. Actas Esp Urol 2003;27(suppl): 28.
142. Zarrindast MR, Farahvash H. Effects of GABAergic drugs on penile erection induced by apomorphine in rats. Psychopharmacology 1994;115: 249-53.
143. Ghadirian AM, Annable L, Belanger MC. Lithium, benzodiazepines, and sexual function in bipolar patients. Am J Psychiatry 1992;149:801-5.
144. Coleman CC, King BR, Bolden-Watson C, Book MJ, Segraves RT, Richard N, Ascher J, Batey S, Jamerson B, Metz A. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 2001;23:1040-58.
145. Gitlin MJ, Suri R, Altshuler L, Zuckerbrow-Miller J, Fairbanks L. Bupropion-sustained release as a treatment for SSRI-induced sexual side effects. J Sex Marital Ther 2002;28:131-8.
146. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med 1992;327:1185-91.
147. Tosti A, Piraccini BM, Soli M. Evaluation of sexual function in subjects taking finasteride for the treatment of androgenic alopecia. J Eur Acad Dermatol Venereol 2001;15:418-21.
148. Schroder FH, Collette L, de Reijke TM, Whelan P. Prostate cancer treated by anti-androgens: Is sexual function preserved? EORTC Genitourinary Group. Br J Cancer 2000;82:283-90.
149. Eri LM, Tveter KJ. Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia. Eur Urol 1994;26:219-26.
150. Basaria S, Lieb J 2nd, Tang AM, Deweese T, Carducci M, Eisenberger M, Dobs AS. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 2002;56:779-86.